Robby Claes

Robby Claes is currently the Head Clinical Quality at Argenx, where they oversee clinical quality initiatives. Previously, they held various leadership roles at Janssen Pharmaceutica, including Director of Clinical Risk Management for Oncology and Director of Quality Planning and Strategy for Immunology, Infectious Diseases, and Vaccines. Robby has a background in operational quality support, process design, and project management, having served in different capacities within Johnson & Johnson from 2002 to 2019. Their academic credentials include a bachelor's degree in bio-engineering from the University of Antwerp.